Lexicon Pharmaceuticals | LXRX - Market Capitalization


Lexicon Pharmaceuticals reported $494.9M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
Insmed USD 35.3B 1.82B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
MannKind USD 757M 984M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
PTC Therapeutics USD 5.64B 460M Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 159M Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024